Please login to the form below

Not currently logged in
Email:
Password:

Cipla

This page shows the latest Cipla news and features for those working in and with pharma, biotech and healthcare.

Pharma must do more on antibiotic resistance, Davos meeting hears

Pharma must do more on antibiotic resistance, Davos meeting hears

although Mylan, Cipla and Fresenius Kabi are doing the best when it comes to ‘stewardship’.

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    contingent payments for the ADHD company Neurovance; Shanghai Fosun paid $90m for a majority interest in Breas (see above); Ascendis Health paid R375m ($29m) for the Southern Africa operations of Cipla ... 60. Cipla Agrimed. Ascendis Health. Acquisition.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Collaboration - option to license. 555. Hetero Drugs. Cipla. Generic US based companies; InvaGen Pharmaceuticals and Exelar Pharmaceuticals.

  • Pharma deals during November 2012 Pharma deals during November 2012

    The second generics acquisition is the offer of $215m by India's Cipla for a 51 per cent stake in South Africa's third largest drug company Cipla Medpro, again driven ... 230. Cipla Medpro / Cipla. Acquisition. Generics. 215. Ensemble Therapeutics /

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Cipla names Adil Zainulbhai to board Cipla names Adil Zainulbhai to board

    He has experience at consulting firm McKinsey &Company. India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director. ... Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to

  • Cipla appoints Novartis’ Subhanu Saxena as CEO Cipla appoints Novartis’ Subhanu Saxena as CEO

    Subhanu Saxena has left Novartis to join India-based generics company Cipla as its new CEO. ... Cipla's chair Dr Yusuf Hamied said: “We are delighted to have found such a good match for Cipla in Subhanu.

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics